Log in

Relevant bibliographies by topics / Benign prostatic hyperplasia

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Benign prostatic hyperplasia'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Benign prostatic hyperplasia.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Benign prostatic hyperplasia"

1

Lorenzo, Guillermo, Thomas J. R. Hughes, Pablo Dominguez-Frojan, Alessandro Reali, and Hector Gomez. "Computer simulations suggest that prostate enlargement due to benign prostatic hyperplasia mechanically impedes prostate cancer growth." Proceedings of the National Academy of Sciences 116, no. 4 (2019): 1152–61. http://dx.doi.org/10.1073/pnas.1815735116.

Full text

Abstract:

Prostate cancer and benign prostatic hyperplasia are common genitourinary diseases in aging men. Both pathologies may coexist and share numerous similarities, which have suggested several connections or some interplay between them. However, solid evidence confirming their existence is lacking. Recent studies on extensive series of prostatectomy specimens have shown that tumors originating in larger prostates present favorable pathological features. Hence, large prostates may exert a protective effect against prostate cancer. In this work, we propose a mechanical explanation for this phenomenon

APA, Harvard, Vancouver, ISO, and other styles

2

Leedahl, David D., Phil H. Vo, Pamela M. Maxson, and Jenna K. Lovely. "Benign Prostatic Hyperplasia." Journal of Pharmacy Practice 26, no. 1 (2012): 52–58. http://dx.doi.org/10.1177/0897190012451913.

Full text

Abstract:

This review provides an update on the treatment of benign prostatic hyperplasia and the pharmacologic considerations for perioperative care. By age 85 years, approximately 90% of men have prostate histologic characteristics consistent with benign prostatic hyperplasia. Pharmacologic treatment with an alpha1 receptor antagonist may reduce symptoms and, when given in combination with a 5-alpha-reductase inhibitor, may decrease the risk of urinary retention and the need for surgical intervention. Transurethral resection of the prostate has been the historical standard when surgical intervention i

APA, Harvard, Vancouver, ISO, and other styles

3

Al-Bazzaz, Wishyar, Omar Alkhayat, and Ali AlKhayat. "Monotherapy versus combination therapy in the treatment of benign prostatic hyperplasia: A single center study." Zanco Journal of Medical Sciences 24, no. 3 (2020): 333–37. http://dx.doi.org/10.15218/zjms.2020.039.

Full text

Abstract:

Background and objectives: Most benign prostatic hyperplasia patients do not present obvious indicators for surgical intervention, so most of these patients are treated initially with medical therapy. This study aimed to compare the incidence of acute urinary retention after treatment with monotherapy with the incidence after combination therapy and determine the need for surgery in both methods. Methods: This is a retrospective study of the medical records of 248 benign prostatic hyperplasia patients who had attended Rizgary Teaching Hospital from May 2012 to June 2017. These patients were di

APA, Harvard, Vancouver, ISO, and other styles

4

Dülgeroğlu, Yakup, Gönül Erden, Musa Ekici, et al. "Diagnostic efficiency of miR-21 and miR-34a serum levels in malign and benign prostate diseases." Yeni Üroloji Dergisi 16, no. 3 (2021): 221–27. http://dx.doi.org/10.33719/yud.2021;16-3-865045.

Full text

Abstract:

Objective: In this study aimed to determine the diagnostic efficiency of miR-21 and miR-34a serum levels in the discrimination of benign prostatic hyperplasia, chronic prostatitis, and prostate cancer. Materials and Methods: Blood samples were taken from 70 patients (25 benign prostatic hyperplasias, 10 chronic prostatitides, and 35 prostate cancer) who underwent prostate needle biopsy. After obtaining serum under suitable conditions, RNA isolation, cDNA synthesis, and qRT-PCR analysis were performed using Qiagen brand kits on Rotor-Gene® Q (Qiagen, Germany) device. -∆Ct values were calculat

APA, Harvard, Vancouver, ISO, and other styles

5

Rahman, Md A., and H. Naushaba. "Impact of Finasteride on Stroma of Benign Hyperplasia of Prostate." Journal of Medical Science & Research 16, Number 1 (2011): 3–8. http://dx.doi.org/10.47648/jmsr.2011.v1601.01.

Full text

Abstract:

Benign prostatic hyperplasia (13P11) is a hyperplastic process of the strontal and epithelial cells of the prostate due to effect of male sex hormone testosterone. Testosterone is the main male sex hormone, responsible for growth of sexual character and accessory sex organs. Despite its effectiveness as an male sex hormone, it causes benign prostatic hyperplasia (BM resulting in urinary dysfunction. On the other hand, finasteride. a 4-azastroid, inhibits the hyperplastic effect of testosterone and benign prostatic hyperplasia. The objective of the study was to observe the effects of finasterid

APA, Harvard, Vancouver, ISO, and other styles

6

Mohammed Ridha Jawad and Ghaith Ali Jasim. "Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model." Al Mustansiriyah Journal of Pharmaceutical Sciences 23, no. 2 (2023): 196–213. http://dx.doi.org/10.32947/ajps.v23i2.1022.

Full text

Abstract:

Background: Benign prostatic hyperplasia [BPH] is the urologic condition that affects elderly men the most frequently Benign prostatic hyperplasia. Benign prostatic hyperplasia must be distinguished from lower urinary tract symptoms and benign prostatic enlargement. which refers to an enlarged prostate, benign prostatic hyperplasia is a purely histological term the development, maintenance, and secretory activity of the prostate and other sex-accessory tissues are stimulated by the presence of certain hormones and growth factors. the pathophysiology of Benign prostatic hyperplasia is sig

APA, Harvard, Vancouver, ISO, and other styles

7

Tang, Ruipeng, and Chuan Xiao. "Correlation between Prostatic Calculi and Benign Prostatic Hyperplasia." Journal of Endocrinology Research 2, no. 1 (2021): 44. http://dx.doi.org/10.30564/jer.v2i1.2518.

Full text

Abstract:

Prostatic calculus is a common disease of the urinary system, Prostate stones are more common in middle-aged and elderly men, With the development of ultrasonic diagnosis, more and more patients with prostate stone were found in physical examination,According to research shows,The vast majority of patients with benign prostatic hyperplasia in the pathogenesis of examination was found to have prostate stones, but so far the correlation between prostate stones and benign prostatic hyperplasia is still not very clear,Benign prostatic hyperplasia is an important factor affecting the physical and m

APA, Harvard, Vancouver, ISO, and other styles

8

Roitberg, G. E., V. V. Astashov, K. G. Mkrtchyan, and A. A. Lomshakov. "Treatment of beneficial prostate hyperplasia of large sizes: traditional surgical, low-invasive and laser technologies (literature review)." Laser Medicine 24, no. 4 (2021): 62–68. http://dx.doi.org/10.37895/2071-8004-2020-24-4-62-68.

Full text

Abstract:

Benign prostatic hyperplasia – one of the most common diseases in older men. The treatment strategy for benign prostatic hyperplasia consists in its drug therapy, or active surgical tactics. The indication for planned surgical treatment of benign prostatic hyperplasia is the progression of symptoms of the lower urinary tract, which are not amenable to drug correction. Men with a large prostate volume of more than 80 m3, with severe symptoms of the lower urinary tract, with a history of acute urinary retention episodes, represent a difficult group of patients in terms of choosing the tactics of

APA, Harvard, Vancouver, ISO, and other styles

9

Kilibayev, Baurzhan, Gafour Khairli, Ulanbek Zhanbyrbekuly, et al. "Giant prostatic enlargement: A presentation of a rare asymptomatic case." Journal of Clinical Medicine of Kazakhstan 20, no. 4 (2023): 71–75. http://dx.doi.org/10.23950/jcmk/13493.

Full text

Abstract:

Benign prostatic hyperplasia is a histological diagnosis and the most frequent benign tumor in older men, and its incidence strongly correlates with advanced age. Giant prostate enlargement (GPE), also known as giant prostatic hyperplasia, is a term given for severely enlarged prostates that weigh more than 500g. GPE cases reported in literature is less than 30. We describe our experience of removing previously asymptomatic 528g prostate by open transvesical prostatectomy. According to transrectal ultrasound (TRUS) the prostate size is 482 ml and prostate‑specific antigen level of 5.1 ng/ml. H

APA, Harvard, Vancouver, ISO, and other styles

10

Kaplan, Steven A. "Benign Prostatic Hyperplasia." Journal of Urology 205, no. 4 (2021): 1199–201. http://dx.doi.org/10.1097/ju.0000000000001612.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Benign prostatic hyperplasia"

1

Jia, Guang. "MR imaging biomarkers for benign prostatic hyperplasia pharmacotherapy." Columbus, Ohio : Ohio State University, 2006. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1164686290.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ambrosini, Gina L. "Dietary risk factors for prostate cancer and benign prostatic hyperplasia." University of Western Australia. School of Population Health, 2008. http://theses.library.uwa.edu.au/adt-WU2008.0135.

Full text

Abstract:

[Truncated abstract] This thesis examines the potential role of dietary intake in the development of two common conditions affecting the prostate gland; prostate cancer and benign prostatic hyperplasia (BPH). Diet is of interest as a potential risk factor for prostate cancer because of geographical variations in prostate cancer incidence and increased prostate cancer risks associated with migration from Asian to western countries. Some geographical variation has been suggested for BPH, but this is less certain. However, both prostate cancer and BPH have potential links with diet through their

APA, Harvard, Vancouver, ISO, and other styles

3

Woo, Henry Hyunshik. "Evolution of minimally invasive surgical treatments for benign prostatic obstruction." Thesis, The University of Sydney, 2016. http://hdl.handle.net/2123/15772.

Full text

Abstract:

Transurethral resection of the prostate (TURP) has been the established surgical gold standard for the treatment of prostatic obstruction due to benign prostatic hyperplasia(BPH). Prior to TURP, the mainstay of surgical treatment was open suprapubic prostatectomy (SPP), which carried a high risk of morbidity and mortality. TURP did not go through rigorous assessment of outcomes or comparison with SPP in order to become labeled as the gold standard. TURP is still a procedure with potential significant morbidity, particular with regard to hemorrhage and surgical misadventure. In the mid to

APA, Harvard, Vancouver, ISO, and other styles

4

Gilmore, Paul Edward. "Isolation and characterization of stem cell phenotype in benign prostatic hyperplasia and prostate cancer." Thesis, University of Manchester, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.492891.

Full text

Abstract:

The prostate epithelial stem cell has been proposed as the primary origin of neoplastic change in prostate cancer. However, due to a lack of specific markers, such cells have been profoundly difficult to isolate. We propose that the Hoechst 33342 dye efflux assay 'Side Population' originally developed to isolate a stem cell enriched haemopoietic stem cell population from bone marrow provides a method for identifying the cancer stem cell origin in prostatic adenocarcinoma.

APA, Harvard, Vancouver, ISO, and other styles

5

Chan, Hin-cheong. "The psychometric evaluation of the Chinese version of the international prostate symptom score (IPSS)." Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B31972871.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Noble, Amanda Jane. "The alphaâ†1-andrenoceptor subtype mediating contraction of the lower urinary tract." Thesis, University of Sheffield, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.284384.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Xu, Kexin. "Identification and evaluation of specific marker proteins associated with human benign peostate [sic] hyperplasia /." Hong Kong : University of Hong Kong, 2002. http://sunzi.lib.hku.hk/hkuto/record.jsp?B25435863.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Fernandes, Ancilla W. "Evaluating diagnostic and treatment modalities in the management of benign prostatic hyperplasia in the Veterans Administration population." Morgantown, W. Va. : [West Virginia University Libraries], 2000. http://etd.wvu.edu/templates/showETD.cfm?recnum=1543.

Full text

Abstract:

Thesis (M.S.)--West Virginia University, 2000.<br>Title from document title page. Document formatted into pages; contains ix, 154 p. : ill. Includes abstract. Includes bibliographical references (p. 137-143).

APA, Harvard, Vancouver, ISO, and other styles

9

Tayeb, Mohammed Taher. "Genetic risk factors influencing the development of prostate cancer in patients with benign prostatic hyperplasia." Thesis, University of Aberdeen, 2002. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU154536.

Full text

Abstract:

The primary aim of this study is to assess the predictive value of six molecular markers in determining PRCa risk in patients with BPH. These molecular markers are: (A)- Two polymorphic repeats, (CAG)<sub>n</sub> and (GGN)<sub>n</sub>, in the androgen receptor (<i>AR</i>) gene; (B)- A single nucleotide polymorphism (SNP) in the (-290 A to G) 5' regulatory region of the <i>CYP3A4 </i>gene; (C)- Two SNPs (<i>Taq</i>I and <i>Fok</i>I) in vitamin D receptor (<i>VDR</i>) gene; (D)- A SNP (Val655Ile) in the transmembrane domain coding region of <i>HER2</i> gene. The study evaluated 28 patients who p

APA, Harvard, Vancouver, ISO, and other styles

10

Hallin, Anders. "Transurethral microwave thermotherapy of benign prostatic hyperplasia : a clinical and methodological evaluation /." Stockholm, 1997. http://diss.kib.ki.se/1997/91-628-2727-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Benign prostatic hyperplasia"

1

Petrovich, Zbigniew, and Luc Baert, eds. Benign Prostatic Hyperplasia. Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-78185-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Jakse, Gerhard, Christian Bouffioux, Jean de Leval, and Rudi A. Janknegt, eds. Benign Prostatic Hyperplasia. Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-77480-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Kirby, Roger S. Benign prostatic hyperplasia. Gower Medical, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

J, Christmas Timothy, ed. Benign prostatic hyperplasia. Gower Medical Publishing, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

International Consultation on Benign Prostatic Hyperplasia (5th 2000 Paris, France). Benign prostatic hyperplasia. Edited by Chatelain C. (Chritian), World Health Organization, and International Union against Cancer. Health Publication, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Physicians, American College of, and Hearst/ABC Viacom, eds. Benign prostatic hyperplasia. Burrells's [distributor], 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

National Institutes of Health (U.S.), ed. Prostate enlargement: Benign prostatic hyperplasia. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

H, Rodgers Charles, National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases (U.S.). Division of Kidney, Urologic, and Hematologic Dieases., and National Institutes of Health (U.S.), eds. Benign prostatic hyperplasia.: A workshop. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Koshiba, Ken, Makoto Miki, Toshiro Terachi, and Toyoaki Uchida, eds. Treatment of Benign Prostatic Hyperplasia. Springer Japan, 2000. http://dx.doi.org/10.1007/978-4-431-68444-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

D, Chisholm Geoffrey, ed. Handbook on benign prostatic hyperplasia. Raven Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Benign prostatic hyperplasia"

1

Good, Daniel W., Bashar Nahas, Simon Phipps, Rick Popert, Jens-Uwe Stolzenburg, and Stuart Alan S. McNeill. "Prostate Benign Prostatic Hyperplasia." In Blandy's Urology. John Wiley & Sons, Ltd, 2019. http://dx.doi.org/10.1002/9781118863343.ch27.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Borchers, H., and G. Jakse. "Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia." In Benign Prostatic Hyperplasia. Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-77480-5_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Riehmann, Morten, and Reginald C. Bruskewitz. "Prostatic Balloon Dilation." In Benign Prostatic Hyperplasia. Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-78185-8_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Lawson, R. K., M. T. Story, S. C. Jacobs, and F. P. Begun. "Growth factors in benign prostatic hyperplasia." In Prostatic Hyperplasia, edited by R. Ackermann and F. H. Schröder. De Gruyter, 1989. http://dx.doi.org/10.1515/9783110847413-008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

DuBeau, Catherine E. "Benign Prostatic Hyperplasia." In Geriatric Medicine. Springer New York, 1997. http://dx.doi.org/10.1007/978-1-4757-2705-0_37.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sotelo, René, Raed A. Azhar, and José Luis Gaona Morales. "Benign Prostatic Hyperplasia." In Prostate Cancer. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-05600-5_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Te, Alexis E., and Bilal Chughtai. "Benign Prostatic Hyperplasia." In Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia. John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118437889.ch16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Powley, Gina M., and Gail M. Briolat. "Benign Prostatic Hyperplasia." In The Nurse Practitioner in Urology. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-45267-4_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Mallhi, Tauqeer Hussain, Erum Ijaz, Muhammad Hammad Butt, et al. "Benign Prostatic Hyperplasia." In Handbook of Medical and Health Sciences in Developing Countries. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-030-74786-2_87-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Briolat, Gail M. "Benign Prostatic Hyperplasia." In The Nurse Practitioner in Urology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-28743-0_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Benign prostatic hyperplasia"

1

Hamel, Kory P. "Technology advancements in the treatment of benign prostatic hyperplasia." In Advanced Photonics in Urology 2025, edited by Hyun Wook Kang, Ronald Sroka, and Jian J. Zhang. SPIE, 2025. https://doi.org/10.1117/12.3050305.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Vaks, Vladimir, Mariya Chernyaeva, Vagif Atduev, et al. "Analysis of Thermal Decomposition Products of Urine at Prostate Cancer and Benign Prostatic Hyperplasia by Terahertz High-Resolution Gas Spectroscopy." In 2024 IEEE 9th All-Russian Microwave Conference (RMC). IEEE, 2024. https://doi.org/10.1109/rmc62880.2024.10846830.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Valvano, Jonathan W., David Y. Yuan, Eric N. Rudie, and Steven J. Clark. "Treatment of Benign Prostatic Hyperplasia." In ASME 1996 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1996. http://dx.doi.org/10.1115/imece1996-0741.

Full text

Abstract:

Abstract The treatment of benign prostatic hyperplasia (BPH) has implications which affect the majority of the adult male population. Although benign compared to prostate cancer, clinical symptoms can dramatically alter the quality of life. The hyperplastic tissue can cause constriction of the urethra and thus affect voiding of urine. Factors to consider for thermally-based treatments of the prostate include minimization of thermal injury to the urethra and rectum, and maximal delivery of thermal energy to target tissue. Minimizing temperature rise in the urethra allows for minimal or no anest

APA, Harvard, Vancouver, ISO, and other styles

4

Chinn, Daniel, Elvis Nditafon, Alvin Yew, and Chandrasekhar Thamire. "Thermal Therapy Protocols for Benign Prostatic Hyperplasia." In ASME 2007 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2007. http://dx.doi.org/10.1115/sbc2007-176764.

Full text

Abstract:

Thermal therapy for treatment of benign prostatic hyperplasia (BPH) is becoming increasingly popular due to the minimally invasive nature of the treatment. Successful management of such therapy requires accurate estimation of thermal dosage. The purpose of this study is to provide correlations for the thermal damage caused by ultrasound, microwave, and infrared devices under a range of operating conditions. A boundary-fitting finite difference method is used to examine the heat transfer in the prostate gland and surrounding tissue. The Pennes bioheat transfer model and a porous media model wer

APA, Harvard, Vancouver, ISO, and other styles

5

GONÇALVES, A. G. F., L. J. M. QUEIROZ, V. K. VIEIRA, et al. "HPV PREVALENCE IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER." In ONCOLOGY 2023 International Symposium. Even3, 2025. https://doi.org/10.29327/oncology-2023-international-symposium.1084753.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Bryant, Richard, and Robert Van den Heuvel. "Novel therapeutic targets for benign prostatic hyperplasia." In 37th Annual EAU Congress, edited by Rachel Giles. Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/e481f274.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Thamire, Chandrasekhar, and Sharath Bellary. "A Numerical Study of Microwave Thermotherapy for Benign Prostatic Hyperplasia." In ASME 2003 Heat Transfer Summer Conference. ASMEDC, 2003. http://dx.doi.org/10.1115/ht2003-47505.

Full text

Abstract:

Transurethral resection of the prostate is the conventional therapy used for relieving bladder-outflow obstruction that typically occurs in older men due to benign prostatic hyperplasia (BPH). Due to the complications and side effects involved, other therapies that are less invasive have been in use over the last few years. The current study examines one such therapy, namely, the transurethral thermal therapy, and its effectiveness as a treatment modality for BPH. The system considered here is capable of delivering microwave energy preferentially into the prostatic tissue. The heat generated i

APA, Harvard, Vancouver, ISO, and other styles

8

McNicholas, Thomas A., and Mohammed Alsudani. "Interstitial laser coagulation therapy for benign prostatic hyperplasia." In Photonics West '96, edited by R. Rox Anderson. SPIE, 1996. http://dx.doi.org/10.1117/12.240022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Muschter, Rolf. "Laser-induced interstitial thermotherapy of benign prostatic hyperplasia and prostate cancer." In International Symposium on Biomedical Optics Europe '94, edited by Stephen G. Bown, J. Escourrou, Frank Frank, et al. SPIE, 1994. http://dx.doi.org/10.1117/12.197575.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Brooks, Lucy. "An introduction to prostatic artery embolisation (PAE) and benign prostatic hyperplasia (BPH)." In Radiopaedia 2025 Virtual Conference. Radiopaedia.org, 2025. https://doi.org/10.53347/rposter-3159.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Benign prostatic hyperplasia"

1

Sciacqua, Lucilla Violetta, Andrea Vanzulli, Rosario Di Meo, et al. Minimally invasive treatment in Benign Prostatic Hyperplasia (BPH). INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0004.

Full text

Abstract:

Condition being studied: Review efficacy and safety of minimally-invasive treatments for Low Urinary Tract Symptoms (LUTS) in patients affected by Benign Prostate Hyperplasia (BPH). These minimally invasive techniques represent a valid alternative for patients who can no longer continue medical therapy or are ineligible to surgery. Eligibility criteria: The inclusion criteria concern the most relevant clinical trials on minimally invasive interventions for Benign Prostatic Hyperplasia (BPH) from January 1993 to January 2022.

APA, Harvard, Vancouver, ISO, and other styles

2

Gradinarska, Desislava, Maria Ivanova, Miroslav Genov, Tsvetan Tsvetkov, and Denica Daskalova. Comparative Assay of Seminal-plasma Proteins in Healthy Dogs and Dogs with Benign Prostatic Hyperplasia. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, 2019. http://dx.doi.org/10.7546/crabs.2019.08.17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Wang, Jiaze, Tingting Deng, Hao Sun, et al. Efficacy and safety of moxisibostion for benign prostatic hyperplasia: a protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.12.0021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Chen, Feng, Yijin Chen, Yongsheng Zou, Yunxiao Wang, Xiaogang Wu, and Milian Chen. Comparison of holmium laser enucleation of prostate and transurethral resection of prostate in patients with benign prostatic hyperplasia: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.5.0065.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Zhang, Xiaolong, Huali Xu, Zhirong Zhu, and Guiliang Tang. The worldwide incidence of bladder neck contracture after transurethral surgery of prostate by thulium laser for benign prostatic hyperplasia: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.4.0007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

London, Richard A., and Mark Byrne. Optimization of Diode Laser System to Treat Benign Prostate Hyperplasia Final Report CRADA No. TSB-1154-95. Office of Scientific and Technical Information (OSTI), 2018. http://dx.doi.org/10.2172/1418927.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

London, R. Optimization of Diode Laser System to Treat Benign Prostate Hyperplasia Final Report CRADA No. TSB-1154-95. Office of Scientific and Technical Information (OSTI), 1998. http://dx.doi.org/10.2172/8426.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

London, R. Optimization of Diode Laser System to Treat Benign Prostate Hyperplasia Final Report CRADA No. TSB-1154-95. Office of Scientific and Technical Information (OSTI), 2000. http://dx.doi.org/10.2172/773232.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!